# FDA Inspection 1014705 - Contacare Ophthalmics & Diagnostics - April 04, 2017

Source: https://www.globalkeysolutions.net/records/fda_inspections/contacare-ophthalmics-diagnostics/efe30888-480f-4f4c-8ae1-03fd02579d6c
Source feed: FDA_Inspections

> FDA Inspection 1014705 for Contacare Ophthalmics & Diagnostics on April 04, 2017. Classification: Official Action Indicated (OAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1014705
- Company Name: Contacare Ophthalmics & Diagnostics
- Inspection Date: 2017-04-04
- Classification: Official Action Indicated (OAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1070443 - 2018-11-01](https://www.globalkeysolutions.net/records/fda_inspections/contacare-ophthalmics-diagnostics/75b7c488-50ea-446f-8cf5-43f873045847)
- [FDA Inspection 832888 - 2013-04-29](https://www.globalkeysolutions.net/records/fda_inspections/contacare-ophthalmics-diagnostics/11d4e6f7-0669-4d50-8bb3-1fcfe375f8ba)

Company: https://www.globalkeysolutions.net/companies/contacare-ophthalmics-diagnostics/069da802-0ebb-4d3a-b872-db4166bde6d6

Office: https://www.globalkeysolutions.net/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c